BIOMAT Database Logo BIOMAT Database Logo

Nephrotoxicity of methyl-CCNU. 1979

W C Nichols, and C G Moertel

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012673 Semustine 4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent. Methyl-CCNU,Me-CCNU,MeCCNU,NSC-95441,Me CCNU,Methyl CCNU,NSC 95441,NSC95441

Related Publications

W C Nichols, and C G Moertel
Nephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy.
December 1981, The American journal of medicine,
W C Nichols, and C G Moertel
Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
November 1977, Cancer treatment reports,
W C Nichols, and C G Moertel
Methyl CCNU therapy linked leukemia.
January 1981, Cancer chemotherapy and pharmacology,
W C Nichols, and C G Moertel
Methyl-CCNU inclinical cancer therapy.
December 1974, Cancer treatment reviews,
W C Nichols, and C G Moertel
Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
January 1975, Cancer chemotherapy reports,
W C Nichols, and C G Moertel
CCNU nephrotoxicity following sustained remission in oat cell carcinoma.
February 1979, Cancer treatment reports,
W C Nichols, and C G Moertel
Leukemia after therapy with methyl CCNU.
January 1980, The New England journal of medicine,
W C Nichols, and C G Moertel
Treatment of malignant melanoma with methyl CCNU.
June 1974, Clinical pharmacology and therapeutics,
W C Nichols, and C G Moertel
Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU.
November 1977, Cancer treatment reports,
W C Nichols, and C G Moertel
99mTc-methyl-CCNU for the static imaging of kidneys.
April 1980, European journal of nuclear medicine,
Copied contents to your clipboard!